SecBot SecBot

RMD

RESMED INC
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000943819 Healthcare & Medical Devices
$238.19 −1.34 (−0.56%)
Nov 16 4:00 PM ET · prev $239.53
Market cap
$33.6B
Large cap
Consensus
Buy
52% Buy or better · 27 analysts
Median target
$270.00
+13% · range $210.00–320.00
1 year
−2.7%
from $244.71 · Nov 17
30 days
−0.7%
from $239.77
52-week range
$182.82–275.96
−14% from high · low Jun 2
Avg volume 20D
1.43M
shares / day
Short interest
10.47M
≈7.4% of shares · −12.2%
Days to cover
7.0
at average volume
Insider net
−$15.6M
0 buyers · 4 sellers · 12 mo
New fund stakes
1
Q2 2026 13F · 2 exits
Filing reports
17
analyzed by SecBot
SecBot read BULLISH 9 reports · 90 days
Balance 1 bearish · 2 bullish · 6 neutral oldest → newest, height = score
Avg score ·High conf. 6/9

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Feb 2 to Feb 9 ▼ 3 days of insider sells: $2.1M by 4 insiders, avg $266.02
  • Mar 2 to Mar 9 ▼ 3 days of insider sells: $2.0M by 3 insiders, avg $253.74
  • Apr 1 to Apr 7 ▼ 2 days of insider sells: $1.8M by 3 insiders, avg $225.23
  • Aug 5 to Aug 7 ▼ 2 days of insider sells: $2.8M by 2 insiders, avg $217.58
  • Sep 2 to Sep 8 ▼ 2 days of insider sells: $1.3M by 2 insiders, avg $224.44
  • Sep 11 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Oct 9
  • Oct 7 ▼ 1 insider sell $1.1M at $226.33
  • Oct 23 ▼ 1 insider sell $102.0K at $255.00
  • Oct 29 ▲ ResMed reported Q1 FY2027 results with revenue of $1.415B (up 6% rep…
  • Oct 29 ▲ Earnings: RMD Q1 2027 Earnings: EPS $2.91 (+7.8% vs est)
  • Nov 2 ▼ Canaccord Genuity downgrades
  • Nov 9 ▼ 1 insider sell $1.2M at $235.35

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $15.6M.

  • InstitutionsMIXED

    Q2 2026: 55 added (1 new), 50 trimmed or exited. Largest new: Sih Partners, Lllp $21.2M.

  • AnalystsBULLISH

    14 of 27 rate it Buy or better. Median target $270.00 (+13%).

  • Short sellersSTEADY

    Short interest −12.2% to 10.47M shares. 7.0 days to cover, ≈7.4% of shares.

  • TrendUPTREND

    3% above its 50-day average.

Who's buying

13F· Q2 2026
1
new positions
2
exits
$21.2M
in new stakes
FundMoveSharesValue
FIRST TRUST ADVISORS LPADD2,278,696$444.1M
MORGAN STANLEYTRIM1,928,931$375.9M
NORDEA INVESTMENT MANAGEMENT ABADD1,388,008$269.6M
UBS Group AGADD1,289,300$251.3M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED1,129,739$220.2M
CITIGROUP INCADD774,425$150.9M
NORGES BANKTRIM664,714$129.5M
AmundiTRIM604,304$117.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

27 analysts
Buy 52% rate it Buy or better
Strong Buy4Buy10Hold11Sell1Strong Sell1
12-month targets · 17 analysts

Price is inside the target range. Median implies +13%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026Canaccord Genuity
DOWNGRADE
DOWNGRADEHold
Oct 30, 2026Citigroup
MAINTAIN
MAINTAINNeutral
Oct 30, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Oct 30, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Oct 30, 2026Keybanc
MAINTAIN
MAINTAINOverweight
Sep 15, 2026RBC Capital
UPGRADE
UPGRADEOutperform

Washington

Corporate Lobbying

20 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$15.6M
sold · 4 insiders
DateInsiderTypeValue
Nov 11, 2026
FARRELL PETER C
Director
Nov 11, 2026
TAX W/H$39.6K
Nov 11, 2026
Bloomer Aaron
Chief Financial Officer
Nov 11, 2026
TAX W/H$256.4K
Nov 11, 2026
Farrell Michael J.
Chairman and CEO
Nov 11, 2026
TAX W/H$811.4K
Nov 11, 2026
Farrell Michael J.
Chairman and CEO
Nov 11, 2026
TAX W/H$517.3K
Nov 11, 2026
Farrell Michael J.
Chairman and CEO
Nov 11, 2026
TAX W/H$570.3K
Nov 11, 2026
Rider Michael J
Global General Counsel
Nov 11, 2026
TAX W/H$128.2K
Nov 11, 2026
Rider Michael J
Global General Counsel
Nov 11, 2026
TAX W/H$116.7K
Nov 11, 2026
Rider Michael J
Global General Counsel
Nov 11, 2026
TAX W/H$169.6K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
RMD trades disclosed by members of Congress, with disclosure delay.
3 members · 5 buys / 2 sells
DateMemberType AmountDisclosed
Sep 11, 2026 Ro KhannaDHouse Child account · Resmed Inc BUY $1K–$15K Oct 7, 2026 +26d
May 27, 2026 Ro KhannaDHouse Spouse account · Resmed Inc BUY $1K–$15K Jun 9, 2026 +13d
May 15, 2026 Ro KhannaDHouse Spouse account · Resmed Inc SELL $1K–$15K Jun 9, 2026 +25d
May 1, 2026 Ro KhannaDHouse Child account · Resmed Inc BUY $1K–$15K Jun 9, 2026 +39d
Apr 13, 2026 Ro KhannaDHouse Spouse account · Resmed Inc BUY $1K–$15K May 11, 2026 +28d
Mar 27, 2026 Alan ArmstrongRSenate Joint account · Resmed Inc BUY $1K–$15K Jul 21, 2026 +116d
May 3, 2024 Tommy TubervilleRSenate Joint account · Resmed Inc SELL $1K–$15K Aug 5, 2026 +824d

Short side

FINRA· Oct 30, 2026
10,471,435
shares short
-12.2%
vs prior settlement
7.0
days to cover
≈7.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 11, 2026 Insider
FARRELL PETER C surrendered for taxes 169.142 shares
Director @ $234.11 ($39.6K)
Nov 11, 2026 Insider
Bloomer Aaron surrendered for taxes 1,095.137 shares
Chief Financial Officer @ $234.11 ($256.4K)
Nov 11, 2026 Insider
Farrell Michael J. surrendered for taxes 3,465.749 shares
Chairman and CEO @ $234.11 ($811.4K)
Nov 9, 2026 Other
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of ResMed Inc. (NYSE: RMD).
NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investiga
Nov 9, 2026 SEC
Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,993 shares of…
144 · Impact 2/10
Oct 29, 2026 SEC
ResMed reported Q1 FY2027 results with revenue of $1.415B (up 6% reported, 7% core constant currency) and GAAP diluted…
8-K · Impact 6/10
Oct 29, 2026 SEC
Resmed reported Q1 FY2027 revenue of $1.415B (up 6% YoY, 7% core constant currency) and non-GAAP diluted EPS of $2.91…
PRESS-RELEASE · Impact 6/10
Sep 11, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 · House
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 9, 2026
Press release
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of ResMed Inc. (NYSE: RMD).
NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of ResMed Inc. (NYSE: RMD) concerning…
Oct 29, 2026
Earnings
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
Oct 29, 2026
Earnings result
RMD Q1 2027 Earnings: EPS $2.91 (+7.8% vs est)
Oct 19, 2026
Press release
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
Resmed announced the U.S. launch of AirTouch F40, the newest addition to its growing portfolio of fabric continuous positive airway pressure (CPAP)…
Oct 1, 2026
Earnings
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for…

SecBot reports

17 filings · 2 press releases · 3 bullish · 3 bearish · 11 neutral
All RMD filing & press-release reports (19)